Advanced Filters
noise

All Participating Sites, Germany Clinical Trials

A listing of All Participating Sites, Germany clinical trials actively recruiting patients volunteers.

Found 64,783 clinical trials

Obtaining Reliable Linguistic and Cultural Validation of the Questionnaires Cargier Bruden Inventony (CBI) and Zarit-12

To validate the 2 questionnaires ZARIT-12 and CBI it is important to go through several stages translation stage : during this stage there will be a meeting of experts to Validate the test version in French by 4 Bilingual translators of the French and English mother tongue. pilot stage : …

18 - 100 years of age All Phase N/A
E Erin Frey

The Ohio State University Dermatology Biorepository

This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.

years of age All Phase N/A

Screening of Patients With Rheumatoid Arthritis for Interstitial Lung Disease

The quantitative and qualitative analysis of RA lung involvement in the Hungarian population

40 years of age All Phase N/A
T Tonya Hibbert

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.

18 years of age All Phase N/A
L Laurent MATHIEU, MD, PhD

Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs

Masquelet's induced membrane technique is a two-stage reconstructive surgery for severe bone fractures commonly used by military orthopedists. The particularity of this technique relies on the synthesis of a biological membrane induced by the transient implantation of a surgical cement (= 1st stage surgery). The presence of the induced membrane …

18 years of age All Phase N/A
D Dominique GENRE, MD

Test of CD47-SIRPα Inhibitors on the Immune Microenvironment Colon Cancer

Our goal is to create novel CD47-SIRPα inhibitors using small molecules to reverse TAM-mediated immune suppression and restore anti-tumor immunity in CRCs. Our program uses structure-based drug design to create selective and potent small molecule inhibitors of SIRPα-CD47 to target the tumor microenvironment with greater efficacy and lower toxicity than …

18 years of age All Phase N/A
H Heidi Jacobe, MD, MSCS

Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository

The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the country. The purpose of the registry is to learn more about morphea, specifically: How morphea behaves over time How frequently specific problems occur along …

- 90 years of age All Phase N/A
N Nancy Fernandez Figueroa

"Pulmonary Rehabilitation Program in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis"

Interstitial Lung Disease associated with Systemic Sclerosis currently represents the main cause of death in this disease, it is also the cause of significant morbidity, which is why pulmonary rehabilitation strategies can be of great benefit in this group of patients. The aim of this study is to determine the …

18 - 75 years of age All Phase N/A
J Jarushka Naidoo, MB

PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN Study

This is a multi-centre, prospective, translational study investigating the use of plasma genotyping for initial genomic testing in newly diagnosed advanced/locally advanced non-squamous NSCLC. In this study, patients will have a plasma genotyping assay completed following confirmation of suspected diagnosis of non-squamous NSCLC at institutional Rapid Access Lung Cancer Clinics …

18 years of age All Phase N/A
S Subash Babu, MBBS, PhD

MISC COVID-19 Study in Pediatric Population

Rationale: Severe Acute Respiratory Syndrome - Coronavirus - 2 (SARS-CoV2) and its related Coronavirus Disease - 19 (COVID-19) has become a health emergency worldwide. The medical community has been concerned since the beginning of the outbreak about the potential impact of COVID-19 in children, especially in those with underlying chronic …

1 - 15 years of age All Phase N/A

Simplify language using AI